Fagron supplies products, services to professionals and institutions in the healthcare sector in Europe, the U.S.A. and Brazil. Co.'s activities are subdivided into four divisions. Through Fagron, Co. offers products and concepts for pharmaceutical compounding. Through Arseus Dental, Co. supplies dental products and concepts to dentists and dental laboratories in Belgium, the Netherlands, France, Germany and Switzerland. Through Arseus Medical, Co. supplies medical and surgical products to specialists, elderly homes, homecare nurses and hospitals in Belgium and the Netherlands. Through Corilus, Co. supplies ICT total solutions for medical specialists in Belgium, the Netherlands and France.
  • TickerFAGR
  • ISINBE0003874915
  • ExchangeEuronext Brussels
  • SectorHealth Care Equipment & Services
  • CountryBelgium
ING
ING Helpdesk

Benelux Morning Notes

Air France-KLM: We can stay blue. Fagron: Extends umbrella agreement with Alliance Healthcare NL

Dave Nicoski ...
  • Ross LaDuke

Vermilion Int'l Compass: Global Equity Strategy

Bottoms-up view on developed int'l, part two Big Picture: Our outlook remains neutral on the MSCI ACWI ex-U.S. index (when priced in local currency) while horizontal consolidation continues. On the other hand, we are negative on broad global ex-U.S. markets when priced in USD... see charts below. In today's report we take a bottoms-up approach to developed ex-U.S. equities, highlighting stocks that present attractive buy opportunities at current levels. Specifically we present actionable stocks within the Communications, Health Care, Manufacturing, Materials, Technology, Transportation, and U...

Fagron Nv: 1 director sold

A director at Fagron Nv sold 3,000,000 shares at 20.200EUR and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

ING
ING Helpdesk

Benelux Morning Notes

Air France-KLM: We can stay blue. Fagron: Extends umbrella agreement with Alliance Healthcare NL

Guy Sips ...
  • Jason Kalamboussis
  • Joachim Vansanten
  • Lenny Van Steenhuyse
  • Sandra Cauwenberghs
  • Thomas Couvreur
  • Wido Jongman

Morning Note: AGS BB, CPINV BB, ENX FP, FAGR BB, INTO BB, TERB BB

Ageas: Settlement of litigation with Modrikamen, no impact CP Invest: No EPRA inclusion after all Euronext: May trading volumes Fagron: Key shareholder Alychlo partially sells stake IO&W: Acquisition of Rietvelden for € 12.1m Ter Beke: Opt for contribution of dividend against new shares

ING
ING Helpdesk

Benelux Morning Notes

Ahold Delhaize: 1Q20 results preview. BE Semiconductor Industries: Performing well despite Covid-19. Brunel International: solid 1Q20 result, trends in April a bit better than feared. Corbion: Raking in the dough. Deceuninck: New chairman and Covid-19 update. Fagron: Highlights from CFO investor call. Fugro: Storms and drydocking did not help 1Q20. KPN: Slight Q1 beat, 2020 guidance at risk due to Covid-19 Proximus: Limited Q1 beat financially, mixed net adds, guidance maintained Royal Dutch Shell: Lowers dividend Telenet Group: Strong Q1, 2020 guidance cut on Covid-19 impact at ...

ING
ING Helpdesk

Benelux Morning Notes

AB InBev: Last chance saloon. ASML: Preview of 1Q20. Boskalis: Acquires Ardent Americas. Fagron: Solid 1Q20 - Compounding slowdown offset by Brands & Essentials growth PostNL: Update on 1Q20 results, with Covid-19 impact SBM Offshore: Capixaba FPSO crew test positive TomTom: Preview of 1Q20

Alan Vandenberghe ...
  • Guy Sips
  • Lenny Van Steenhuyse
  • Ruben Devos
  • Wido Jongman
  • Wim Hoste

Morning Note: ABI BB, COLR BB, OPTI BB , FAGR BB, JEN BB, PIC BB, PNL NA, XIOR BB

AB InBev: Halves final dividend to € 0.50 per share Colruyt: From windfarm to fork Crescent: Working together with WMW to offer Covid solutions Fagron: Net positive effect of COVID-19 in 1Q20 Jensen-Group: Significant slowdown in order intake – No dividend Picanol: Restarting production at its Ieper plant as of today PostNL: Covid-19 update Xior: Securing liquidity - diversifying debt base

FAGRON loses on its star level and is downgraded to Slightly Positive

The independent financial analyst theScreener just slightly lowered the general evaluation of FAGRON (BE), active in the Medical Equipment industry. The title has lost a star(s) at the fundamental level and now shows 3 out of 4 stars. Its exposure to market risk remains nonetheless the same and can be still described as defensive. theScreener slightly downgrades the general evaluation to Slightly Positive for the title on account of the lost star(s). As of the analysis date February 25, 2020, the closing price was EUR 20.00 and its potential was estimated at EUR 23.03.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch